Skip to main content
Log in

Comment on: “Morbidly Obese Patients Exhibit Increased CYP2E1-Mediated Oxidation of Acetaminophen”

  • Letter to the Editor
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 08 May 2018

The Original Article was published on 27 January 2016

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. van Rongen A, Valitalo PA, Peeters MY, et al. Morbidly obese patients exhibit increased CYP2E1-mediated oxidation of acetaminophen. Clin Pharmacokinet. 2016;55(7):833–47.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Reith D, Medlicott NJ, De Silva RK, et al. Simultaneous modelling of the Michaelis–Menten kinetics of paracetamol sulphation and glucuronidation. Clin Exp Pharmacol Physiol. 2009;36(1):35–42.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David M. Reith.

Ethics declarations

Conflict of interest

David Reith has no conflict of interest to declare relating to this letter.

Funding

No funding was received in the preparation of this letter.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Reith, D.M. Comment on: “Morbidly Obese Patients Exhibit Increased CYP2E1-Mediated Oxidation of Acetaminophen”. Clin Pharmacokinet 57, 895–896 (2018). https://doi.org/10.1007/s40262-018-0666-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40262-018-0666-1

Navigation